Todd Young
Director of Finance/CFO chez ELANCO ANIMAL HEALTH INCORPORATED
Fortune : 4 M $ au 31/03/2024
Postes actifs de Todd Young
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Director of Finance/CFO | 14/12/2018 | - |
Historique de carrière de Todd Young
Anciens postes connus de Todd Young
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 22/08/2016 | 31/10/2018 |
| Director of Finance/CFO | 22/08/2016 | 31/10/2018 | |
| Sidley & Austin | Corporate Officer/Principal | - | - |
| BAXALTA INC | Corporate Officer/Principal | - | - |
| Treasurer | - | - | |
| BAXTER INTERNATIONAL INC. | Treasurer | 01/01/2001 | - |
Formation de Todd Young
| Grinnell College | Undergraduate Degree |
| The University of Michigan Law School | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Treasurer | 2 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
| Sidley & Austin | Commercial Services |
- Bourse
- Insiders
- Todd Young
- Expérience
